Instituto Universitario de Bio-Orgánica Antonio González
Forschungsinstitut
Bonifacio N.
Díaz Chico
Publikationen, an denen er mitarbeitet Bonifacio N. Díaz Chico (3)
2019
-
A novel naphthoquinone-coumarin hybrid that inhibits BCR-ABL1-STAT5 oncogenic pathway and reduces survival in imatinib-resistant chronic myelogenous leukemia cells
Frontiers in Pharmacology, Vol. 9, Núm. JAN
2017
-
CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia
Oncotarget, Vol. 8, Núm. 18, pp. 29679-29698